Table 2 Clinical data of the ESRD patients in survival and mortality groups

Male/female

25/18

5/3

1.000

Age (year)

55 (52–65)

66 (62–70)

0.087

Height (cm)

170 (162–178)

168 (166–171)

0.595

Weight (kg)

83 (72–101)

76 (65–93)

0.223

BMI (kg/m²)

30.22 (24.39–34.29)

26.28 (24.09–31.76)

0.214

BP_SYS (mmHg)

141 (127–169)

146 (123–183)

0.866

BP_DIA (mmHg)

77 (69–83)

71 (58–88)

0.517

Smoking, n (%)

5 (11.6)

1 (12.5)

1.000

Diabetes Mellitus, n (%)

25 (58.1)

7 (87.5)

0.672

Hypertension, n (%)

43(100)

8 (100)

1.000

Duration of dialysis (year)

3 (2–6)

3 (2–7)

0.793

LVEF (%)

60 (55–64)

62 (51–85)

0.370

Kt/V

1.42 (1.24–1.61)

1.44 (1.25–1.64)

0.776

URR (%)

74 (70–79)

75 (69–80)

0.640

nPCR

0.85 (0.69–0.96)

0.95 (0.76–1.05)

0.158

Sodium (mEq/dL)

139 (137–141)

139 (137–142)

0.886

Potassium (mEq/dL)

5.0 (4.4–5.3)

5.2 (4.5–5.5)

0.357

Chloride (mEq/dL)

100 (97–103)

100 (97–103)

0.897

Bicarbonite (mEq/dL)

27 (23–29)

22 (21–25)

0.065

Blood Urea Nitrogen (mg/dL)

56 (43–70)

70 (50–89)

0.214

Creatinine (mg/dL)

8.3 (6.6–9.5)

9.0 (6.6–11.0)

0.595

Glucose (mg/dL)

106 (88–143)

110 (81–136)

0.698

Calcium (mg/dL)

8.8 (8.4–9.2)

8.6 (6.8–9.1)

0.232

Phosphate (mg/dL)

5.2 (3.9–6.0)

5.6 (4.8–6.6)

0.249

Calcium Phosphate Product

44.5 (35.5–51.3)

46.0 (42.0–49.7)

0.679

Albumin (g/dL)

4.0 (3.8–4.2)

4.0 (3.5–4.3)

0.630

Hemoglobin (g/dL)

11.7 (10.9–12.3)

11.6 (11.2–12.7)

0.688

Hematocrit (%)

36.0 (33.0–38.0)

37.0 (36.0–39.0)

0.076

β-blocker, n (%)

29 (67.4)

5 (62.5)

0.541

CCB, n (%)

20 (46.5)

5 (62.5)

0.329

ACEI, n (%)

13 (30.2)

2 (25.0)

0.565